lobbying_activities: 1802747

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1802747	b63bb5e5-bfda-4048-9b2f-46da9b835851	1T	DALRYMPLE & ASSOCIATES, LLC	5073	EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION)	2016	first_quarter	HOM	Increased appropriations for CDC strategic national stockpile; increased appropriations for BARDA CBRN MCM advanced development; inceased appropriations for Project BioShield SRF; HR1300/S.1915-making anthrax vaccine available to 1st responders from the SNS prior to shelf live expiration for voluntary vaccination programs & HR 3299 for FDA priority review vouchers for developers of FDA approved MCMs against WMD CBRN threats.Contracting with CDC, HHS ASPR, BARDA and NIH for FDA licensed anthrax vaccine, botulinum antitoxin, AIGIV, BIGIV, VIGIV, third generation anthrax vaccine advanced development, RSDL for CHEMPACK,	Air Force, Dept of,Army, Dept of (Other),Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),Defense Logistics Agency,Defense Threat Reduction Agency (DTRA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Joint Chiefs of Staff,Natl Institutes of Health (NIH),SENATE,White House Office	31000		0	1	2016-04-02T13:37:58.370000-04:00